股票代码：002768 股票简称：国恩股份 公告编号：2025-032 青岛国恩科技股份有限公司 第五届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 青岛国恩科技股份有限公司（以下简称"公司"或"国恩股份"）第五届董 事会第十三次会议于 2025 年 6 月 6 日下午 16:00 在青岛市城阳区棘洪滩街道青 大工业园 2 号路公司办公楼四楼会议室召开。本次会议由公司董事长王爱国先生 召集并主持，会议通知于 2025 年 6 月 3 日以专人送达、电子邮件、电话等形式 发出。本次会议采取现场表决的方式召开，应参加本次会议表决的董事 7 人，实 际参加本次会议表决的董事为 7 人，公司高级管理人员列席了本次会议。本次会 议的召集、召开和表决程序符合《中华人民共和国公司法》（以下简称《公司法》） 和《青岛国恩科技股份有限公司章程》（以下简称《公司章程》）的有关规定， 合法有效。 二、董事会会议审议情况 1、审议通过《关于调整公司董事会专门委员会组成人员的议案》 王亚平（主任委员）、孙建强、李慧颖 表决结果：同意 ...

Group 1 - The acrylic acid concept sector rose by 1.88%, ranking 7th among concept sectors, with 8 stocks increasing in value, including Bohai Chemical which hit the daily limit, and Shuangxiang Co., Shenyang Chemical, and Baolijia showing gains of 4.49%, 2.93%, and 2.59% respectively [1] - The main inflow of funds into the acrylic acid concept sector was 158 million yuan, with Bohai Chemical leading the net inflow at 86.73 million yuan, followed by Wanhua Chemical, Satellite Chemical, and Rike Chemical with net inflows of 71.24 million yuan, 17.03 million yuan, and 11.80 million yuan respectively [2] - In terms of net inflow ratios, Bohai Chemical, Shenyang Chemical, and Rike Chemical had the highest ratios at 14.08%, 5.97%, and 5.93% respectively [3] Group 2 - The top stocks in the acrylic acid concept sector included Bohai Chemical with a daily increase of 10.10% and a turnover rate of 13.09%, while Wanhua Chemical increased by 1.14% with a turnover rate of 0.77% [3][4] - Stocks that experienced declines included Tianlong Group, which fell by 0.98%, and Benli Technology and Acoly, both down by 0.35% [1][4] - The overall performance of the acrylic acid concept sector indicates a positive trend, with significant capital inflows and several stocks showing strong gains [2][3]

Core Viewpoint - On May 26, 2025, Guoen Technology Co., Ltd. announced plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international capital operations and accelerate the establishment of a dual circulation pattern in the domestic and international markets [1][5]. Group 1: H-Share Issuance and Listing - The company plans to issue H-shares not exceeding 15% of the total share capital post-issuance, with proceeds allocated for establishing a Hong Kong regional headquarters, R&D investments, capacity expansion, strategic investments, and operational funding [1][5]. - The issuance and listing are subject to shareholder approval and regulatory approvals [1]. Group 2: Management Changes - On the same day, the company announced the resignation of two board members, Zhang Shide and Liu Shuyuan, due to personal reasons, with no impact on the board's legal quorum [1][2]. Group 3: Company Overview and Financial Performance - Founded in December 2000 and listed in June 2015, Guoen Group has developed a diversified portfolio in green petrochemicals, organic polymers, and health-related products, among others [4]. - In 2024, the company reported revenue of 19.219 billion yuan, a 10.21% increase from the previous year, and a net profit of 676 million yuan, up 45.18% year-on-year [4]. - The chemical industry segment generated 17.369 billion yuan, accounting for 90.38% of total revenue, while the health industry segment saw a decline in revenue [4]. Group 4: Recent Financial Results - In Q1 2025, the company reported revenue of 4.412 billion yuan, a slight decrease of 0.23%, and a net profit of 111 million yuan, down 9.79% year-on-year [5]. - As of March 31, 2025, total assets were 18.971 billion yuan, a 23.71% increase year-on-year, while total liabilities rose by 34.64% to 11.866 billion yuan [5].

Group 1 - The epoxy propylene sector experienced a decline of 1.90%, ranking among the top losers in the concept sector, with notable declines from companies such as Hongqiang Co., Kent Catalysis, and Hongbaoli [1] - The top gainers in the epoxy propylene sector included Bohai Chemical, Guoen Co., and Zhongchumai, with increases of 3.05%, 0.95%, and 0.69% respectively [1] - The overall market saw a net outflow of 347 million yuan from the epoxy propylene sector, with 17 stocks experiencing net outflows, and 7 stocks seeing outflows exceeding 10 million yuan [1] Group 2 - Hongbaoli led the net outflow with 198 million yuan, followed by Hangjin Technology, Hongqiang Co., and Kent Catalysis, with net outflows of 44.63 million yuan, 39.58 million yuan, and 24.99 million yuan respectively [1] - The top net inflows in the sector were seen in Bohai Chemical, Sinochem International, and China Chemical, with net inflows of 25.68 million yuan, 9.25 million yuan, and 1.62 million yuan respectively [2] - The trading volume for Hongbaoli was 21.49%, while the trading volume for Bohai Chemical was 9.36% [2]

Group 1 - Company plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to advance its global strategy and enhance its international capital operation platform [1] - The company aims to consider the interests of existing shareholders and the conditions of domestic and international capital markets when determining the timing and window for the issuance [1] - As of now, the company has developed a vertically integrated industrial cluster in new chemical materials, including green petrochemicals and biodegradable materials [1] Group 2 - In the large chemical industry, the company focuses on creating three main business engines: green petrochemical materials, organic polymer modified materials, and organic polymer composite materials [2] - The subsidiary, Dongbao Biological, specializes in the research, production, and sales of gelatin and collagen products, providing comprehensive solutions for downstream users [2] - The company operates both B2B and B2C business models, with B2B products including gelatin and collagen used in various sectors such as healthcare and beauty [2] Group 3 - In 2024, the company will focus on its main business, leveraging its vertical integration in the large chemical and health industries to drive growth [3] - The company expects to achieve a revenue of 19.22 billion yuan, a year-on-year increase of 10.21%, and a net profit of 676 million yuan, a year-on-year increase of 45.18% [3]

Core Viewpoint - Guoen Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international capital operation platform and accelerate the construction of a dual circulation pattern in the domestic and international markets [1] Group 1: Company Overview - Guoen Co., Ltd. was established in 2000 and is headquartered in Qingdao, focusing on two core industries: large chemicals and health [1] - The company operates a vertically integrated industrial platform and implements a "one body, two wings" development strategy, forming a chemical new materials industry cluster [1] - The company has a strong presence in the health sector through its subsidiary Dongbao Biological, which specializes in gelatin and collagen products [1] Group 2: Chemical Sector Performance - In the new energy vehicle sector, the company is increasing market share in modified materials such as PP, PC, ABS, PA, and PMMA [2] - The company has a current production capacity of 1.08 million tons for organic polymer modified materials, 400,000 tons for organic polymer composite materials, and 900,000 tons for green petrochemical materials [2] - In 2024, the chemical sector achieved revenue of 17.369 billion yuan, accounting for 90.38% of total revenue, with a year-on-year growth of 11.62% [3] Group 3: Health Sector Performance - The health sector, led by Dongbao Biological, has an annual gelatin production capacity of 13,500 tons and a future capacity of 70 billion capsules [4] - In 2024, the health sector generated revenue of 885 million yuan, representing 4.6% of total revenue [4] Group 4: Overall Financial Performance - In 2024, Guoen Co., Ltd. reported total revenue of 19.220 billion yuan, a year-on-year increase of 10.21%, with a net profit of 676 million yuan, up 45.18% year-on-year [4] - The company reported a slight decline in revenue and net profit in Q1 2025 compared to the same period last year, with total revenue of 4.412 billion yuan, down 0.23% year-on-year [4]

Core Viewpoint - The company, Qingdao Guoen Technology Co., Ltd., has announced the addition of temporary proposals for the 2024 Annual General Meeting of Shareholders scheduled for June 6, 2025, which includes 14 specific proposals related to the issuance of H shares and other corporate governance matters [2][3]. Group 1: Meeting Details - The 2024 Annual General Meeting will be held on June 6, 2025, at 14:00, with network voting available from 9:15 to 15:00 on the same day [2][3]. - Shareholders must hold shares by the registration date of May 30, 2025, to attend the meeting [4]. - Voting can be conducted either in person or through an online platform, with specific procedures outlined for both methods [3][8]. Group 2: Proposals for Consideration - The temporary proposals include significant items such as the issuance of H shares, the establishment of a plan for the use of funds raised, and the appointment of auditors [2][3][6]. - The proposals also cover amendments to the company's articles of association and the election of non-independent and independent directors [2][3][6]. Group 3: Shareholder Participation - All ordinary shareholders or their proxies registered by the cut-off date are entitled to attend and vote at the meeting [4][5]. - Proxy voting is allowed, and the proxy does not need to be a shareholder of the company [5][8]. - Specific documentation is required for both corporate and individual shareholders to register for the meeting [7][8].

股票代码：002768 股票简称：国恩股份 公告编号：2025-024 青岛国恩科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 青岛国恩科技股份有限公司（以下简称"公司"或"国恩股份"）第五届监 事会第十一次会议于 2025 年 5 月 26 日 15:30 在青岛市城阳区棘洪滩街道青大工 业园 2 号路公司四楼会议室召开。本次会议由监事会主席王龙先生提议召开并主 持，会议通知于 2025 年 5 月 23 日以专人送达、电子邮件、电话等形式发出。本 次会议应到监事 3 名，实到监事 3 名。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》（以下简称"《公司法》"）等法律法规和《青岛国 恩科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，合法有 效。 二、监事会会议审议情况 议案》 公司发行境外上市外资股（H 股）股票并申请于香港联合交易所有限公司 （以下简称"香港联交所"）主板挂牌上市（以下简称"本次发行"、"本次发 行上市"或"本次发行并上市"）有利于深入推进公司全球化战略布局，打造国 际化 ...

股票代码：002768 股票简称：国恩股份 公告编号：2025-026 青岛国恩科技股份有限公司 二、补选董事情况 韩博先生，1982 年 6 月出生，中国国籍，无永久境外居留权，硕士研究生 学历，高级工程师。共获得发明专利 7 项、外观设计专利 1 项、实用新型专利 技集团；2010 年 8 月至 2011 年 7 月，任公司前身青岛国恩科技发展有限公司总 经理助理；2011 年 8 月至 2013 年 8 月，任公司总经理助理；2013 年 8 月起， 担任公司副总经理；现任公司副总经理、山东国恩化学有限公司执行董事兼总 经理、国恩一塑（浙江）新材料科技有限公司董事、广东国恩塑业发展有限公 司经理、国恩未来（广东）塑业销售有限公司经理、浙江国恩化学有限公司经 理。 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事辞职情况 青岛国恩科技股份有限公司（以下简称"公司"）董事会近日收到公司董 事张世德先生、独立董事刘树艳女士的辞职报告。张世德先生因个人原因申请 辞去公司董事职务，辞职后，将继续在公司下属子公司青岛益青生物科技股份 有限公司任职；刘树艳女士 ...

Group 1 - The candidate, Xiang Ting, has been nominated as an independent director for Qingdao Guo'en Technology Co., Ltd. and has confirmed understanding and agreement with the nomination [1] - The candidate asserts that there are no relationships that could affect independence and meets the qualifications required by relevant laws and regulations [1][2] - The candidate has undergone qualification review by the nomination committee and has no conflicts of interest with the nominator [1][2] Group 2 - The candidate confirms compliance with the requirements set forth by the China Securities Regulatory Commission and the Shenzhen Stock Exchange for independent directors [1][2] - The candidate has participated in training and will obtain the necessary independent director qualification certificate recognized by the Shenzhen Stock Exchange [2][3] - The candidate has the requisite knowledge and experience in corporate operations, with over five years in relevant fields such as law, economics, management, accounting, or finance [4][5] Group 3 - The candidate and their immediate family do not hold positions in the company or its subsidiaries, nor are they significant shareholders [5][6] - The candidate has not been subject to any disqualifying actions by regulatory authorities, such as being barred from serving as a director [7][8] - The candidate commits to fulfilling the responsibilities of an independent director diligently and independently, without influence from major shareholders or related parties [9][10]